Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Dr. Genovese comments

Mark Genovese¹

¹Stanford University, Rheumatology, 1000 Welch Road #203, Palo Alto, California 94304, USA. genovese@stanford.edu.

The Journal of Rheumatology

|October 3, 2015

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4.

Modern rheumatology·2024

Same author

Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.

Modern rheumatology·2022

Same author

Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).

Modern rheumatology·2022

Same author

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.

Annals of the rheumatic diseases·2021

Same author

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2021

Same author

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Arthritis care & research·2021